JP2024520427A5 - - Google Patents
Info
- Publication number
- JP2024520427A5 JP2024520427A5 JP2023572797A JP2023572797A JP2024520427A5 JP 2024520427 A5 JP2024520427 A5 JP 2024520427A5 JP 2023572797 A JP2023572797 A JP 2023572797A JP 2023572797 A JP2023572797 A JP 2023572797A JP 2024520427 A5 JP2024520427 A5 JP 2024520427A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence shown
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192783P | 2021-05-25 | 2021-05-25 | |
| US63/192,783 | 2021-05-25 | ||
| PCT/US2022/030814 WO2022251283A1 (en) | 2021-05-25 | 2022-05-25 | T cell receptors targeting ras mutations and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520427A JP2024520427A (ja) | 2024-05-24 |
| JP2024520427A5 true JP2024520427A5 (cg-RX-API-DMAC7.html) | 2025-06-03 |
Family
ID=84230235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572797A Pending JP2024520427A (ja) | 2021-05-25 | 2022-05-25 | Ras変異を標的とするt細胞受容体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240091361A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4347639A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024520427A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240013750A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117545766A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022283277A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023024595A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219923A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308755A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014073A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022251283A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4573114A4 (en) * | 2022-08-19 | 2026-07-29 | Memorial Sloan Kettering Cancer Center | T-LYMPHOCYTE RECEPTORS TARGETTING RAS MUTATIONS AND ASSOCIATED USES |
| US20260232734A1 (en) * | 2023-02-27 | 2026-08-13 | Adaptive Biotechnologies Corporation | Therapeutic T-Cell Receptors Targeting KRAS G12D |
| CN118812698A (zh) * | 2023-04-19 | 2024-10-22 | 香雪生命科学技术(广东)有限公司 | 一种识别kras突变的高亲和力t细胞受体及其应用 |
| KR20260024373A (ko) * | 2023-05-05 | 2026-02-20 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 다중-수용체 자연 살해 세포 |
| WO2025054164A1 (en) * | 2023-09-05 | 2025-03-13 | Bluesphere Bio, Inc. | T cell receptors targeting an npm1 neoantigen |
| AU2024408100A1 (en) * | 2023-12-22 | 2026-08-06 | Abata Therapeutics, Inc. | Cell therapies for type 1 diabetes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| MX2020001879A (es) * | 2017-08-18 | 2020-07-29 | Gritstone Oncology Inc | Proteínas de fijación al antígeno que se dirigen a antígenos compartidos. |
| MX2020005765A (es) * | 2017-12-04 | 2020-09-25 | Us Health | Receptores de celulas t restringidos a antigeno leucocitario humano (hla) clase i contra sarcoma de rata (ras) mutado. |
| US20200129555A1 (en) * | 2018-10-24 | 2020-04-30 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Hla-a3-restricted t cell receptors against mutated ras |
| CA3127673A1 (en) * | 2019-01-25 | 2020-07-30 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting mutant ras |
| GB2613715B (en) * | 2019-02-20 | 2023-12-06 | Fred Hutchinson Cancer Center | Binding proteins specific for RAS neoantigens and uses thereof |
-
2022
- 2022-05-25 KR KR1020237041629A patent/KR20240013750A/ko active Pending
- 2022-05-25 AU AU2022283277A patent/AU2022283277A1/en active Pending
- 2022-05-25 BR BR112023024595A patent/BR112023024595A2/pt not_active Application Discontinuation
- 2022-05-25 CN CN202280045185.0A patent/CN117545766A/zh active Pending
- 2022-05-25 IL IL308755A patent/IL308755A/en unknown
- 2022-05-25 WO PCT/US2022/030814 patent/WO2022251283A1/en not_active Ceased
- 2022-05-25 MX MX2023014073A patent/MX2023014073A/es unknown
- 2022-05-25 CA CA3219923A patent/CA3219923A1/en active Pending
- 2022-05-25 EP EP22812027.5A patent/EP4347639A4/en active Pending
- 2022-05-25 JP JP2023572797A patent/JP2024520427A/ja active Pending
-
2023
- 2023-11-22 US US18/517,835 patent/US20240091361A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527635A5 (cg-RX-API-DMAC7.html) | ||
| JP7781243B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| JP7803939B2 (ja) | Kras変異に特異的t細胞受容体のスクリーニング及び抗腫瘍用途 | |
| US20240024359A1 (en) | BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 | |
| AU2017371260B2 (en) | T cell receptors with improved pairing | |
| JP7340127B2 (ja) | がんに対する免疫療法で使用するための形質移入t細胞およびt細胞受容体 | |
| ES2968802T3 (es) | Células T transfectadas y receptores de células T para su uso en inmunoterapia contra el cáncer | |
| JP2021533777A5 (cg-RX-API-DMAC7.html) | ||
| JP2022050400A5 (cg-RX-API-DMAC7.html) | ||
| JP2021520831A5 (cg-RX-API-DMAC7.html) | ||
| JP2017523784A5 (cg-RX-API-DMAC7.html) | ||
| JP2017536825A (ja) | 抗突然変異kras t細胞受容体 | |
| JP2025063321A5 (cg-RX-API-DMAC7.html) | ||
| JP2022527267A5 (cg-RX-API-DMAC7.html) | ||
| JP2022528030A5 (cg-RX-API-DMAC7.html) | ||
| CN112930394A (zh) | 表达ii类主要组织相容性复合物的癌细胞疫苗和用于产生整合免疫应答的使用方法 | |
| US12421290B2 (en) | CD22-specific T cell receptors and adoptive T cell therapy for treatment of B cell malignancies | |
| CA3115022A1 (en) | Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy | |
| JP2022537553A5 (cg-RX-API-DMAC7.html) | ||
| JP2022548112A5 (cg-RX-API-DMAC7.html) | ||
| JP2022502078A5 (cg-RX-API-DMAC7.html) | ||
| JP2023540123A5 (cg-RX-API-DMAC7.html) | ||
| Parsons et al. | A novel CEA vaccine stimulates T cell proliferation, γIFN secretion and CEA specific CTL responses | |
| JP2023526416A5 (cg-RX-API-DMAC7.html) | ||
| JP2023052688A (ja) | 対合が改善されたt細胞受容体t細胞 |